Inventor · disambiguated record

Liang Xiao

Also filed as: XIAO LIANG · XIAO LIANG YONG

26 granted patents·18 pending applications·14 citations·filing 2015–2025

92Inventor score

Technology areasA61K C07K G01N A61P A23L

Files withSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD21 BGI SHENZHEN11 CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD3 MEDILINK THERAPEUTICS SUZHOU CO LTD2 AMPSOURCE BIOPHARMA SHANGHAI INC1

Top patents by PatentIndex Score

44 records

0184US11338000B2Use of Butyribacter intestini in preventing and/or treating inflammation-related diseasesBGI SHENZHEN·Filed 2017·Granted May 24, 2022·2 cites·18 claims
0280US11136413B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 5, 2021·1 cites·40 claims
0379US11160837B2Megamonas funiformis and applications thereofBGI SHENZHEN·Filed 2017·Granted Nov 2, 2021·1 cites·10 claims
0479US11155632B2Anti-CD47 monoclonal antibody and use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 26, 2021·2 cites·11 claims
0578US12297265B2Antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted May 13, 2025·1 cites·43 claims
0678US10465014B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 5, 2019·1 cites·64 claims
0777US12258419B2Anti-FXI/FXIa antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 25, 2025·1 cites·27 claims
0877US11376289B2Composition and uses thereofBGI SHENZHEN·Filed 2018·Granted Jul 5, 2022·2 cites·20 claims
0977US2024382612A1Bioactive conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
1074US2023293536A1Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
1173US2023357259A1Bioactive conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
1270US11884725B2Antibody against TIM-3 and application thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Granted Jan 30, 2024·1 cites·20 claims
1370US2025340630A1Antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
1466US11970506B2Bioactive molecule conjugate, preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 30, 2024·0 cites·22 claims
1566US11903948B2Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 20, 2024·0 cites·7 claims
1663US10494661B2Stabilizer for preserving biological samplesBGI SHENZHEN·Filed 2015·Granted Dec 3, 2019·1 cites·12 claims
1761US10806759B2Christensenella intestinihominis and application thereofBGI SHENZHEN·Filed 2016·Granted Oct 20, 2020·0 cites·19 claims
1861US2025332272A1Preparation method for drug linker conjugate and intermediate thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
1960US12344669B2Anti-CD47 monoclonal antibody and use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 1, 2025·0 cites·14 claims
2059US2025325688A1Antibody-drug conjugate containing protein degradation agent bioactive compound, method for preparing same, and use thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
2158US11903981B2Use of Anaerofustis stercorihominis in preventing and/or treating metabolic diseasesBGI SHENZHEN·Filed 2018·Granted Feb 20, 2024·0 cites·15 claims
2256US2025144229A1Conjugate of antibody-eribulin or derivative thereof, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and use thereofMEDLINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
2355US11145987B2Ultralight artificial medium multilayer cylindrical lensXIAN XIAO SANTENNA TECH CO LTD·Filed 2018·Granted Oct 12, 2021·1 cites·7 claims
2454US2024016775A1Anti-coronavirus application of poly adp ribose polymerase inhibitorFUKANG SHANGHAI HEALTH TECH CO LTD·Filed 2021·Application pending·0 cites
2554US2022008553A1Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
2654US2025223352A2Anti-nectin-4 antibody, conjugate including the same, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
2753US2023338565A1Antibody drug conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
2852US2023203178A1Chimeric antigen receptor car or car construct targeting bcma and cd19 and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
2951US11191790B2Biologically pure Faecalibacterium butyricigenerans strain, composition including the same and method for treating ulcerative colitisBGI SHENZHEN·Filed 2019·Granted Dec 7, 2021·0 cites·13 claims
3051US2022363781A1Anti-tslp antibody and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
3151US2021146097A1Catheter positioning deviceSHANGHAI CORINLINE MEDICAL TECH CO LTD·Filed 2021·Application pending·0 cites
3250US12121549B2Application of Alistipes shahii in preparing a composition for preventing and/or treating lipid metabolism related diseasesBGI SHENZHEN·Filed 2017·Granted Oct 22, 2024·0 cites·18 claims
3350US11655295B2Anti-LAG-3 antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted May 23, 2023·0 cites·28 claims
3450US11273186B2Application of bacteroides cellulosityticus in preparing a preparation for preventing and/or treating lipid metabolism related diseasesBGI SHENZHEN·Filed 2017·Granted Mar 15, 2022·0 cites·20 claims
3549US2025269026A1Chimeric antigen receptor which specifically binds to msln, and application thereofCHENGDU KELUN PREC BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
3648US2023287122A1Anti-pd-l1 antibody preparationHARBOUR BIOMED THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
3748US2019076438A1Anti-erbb2 antibody-drug conjugate and composition thereof, preparation method therefor, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
3847US11207420B2Cytotoxin and conjugate, uses of same and preparation method thereforSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 28, 2021·0 cites·36 claims
3946US12258386B2Humanized anti-A β monoclonal antibody and application thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 25, 2025·0 cites·9 claims
4046US2024425593A1Anti-pd-1 antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
4145US12150944B2Use of anti-HER2 antibody-drug conjugate in cancer treatmentSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 26, 2024·0 cites·26 claims
4243US12251407B2Use of Megamonas funiformis in preventing and/or treating metabolic diseasesBGI SHENZHEN·Filed 2018·Granted Mar 18, 2025·0 cites·19 claims
4343US10799540B2Faecalibacterium longum and application thereofBGI SHENZHEN·Filed 2016·Granted Oct 13, 2020·0 cites·20 claims
4438US11421029B2Recombinant bispecific antibodies to PD-L1 and CTLA-4SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 23, 2022·0 cites·40 claims

Join the waitlist — get patent alerts

Get an alert when Liang Xiao files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →